Daffy

Treatments for epilepsy and symptoms of Slc13a5 Foundation

Treatments for epilepsy and symptoms of Slc13a5 Foundation

Menlo Park, CA 94026
Tax ID47-3108868

Want to make a donation using Daffy?

Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.

Payment method

Frequency

Amount

$USD
Daffy covers all ACH transaction fees so 100% of your donation goes to your favorite charities.

Do you work for Treatments for epilepsy and symptoms of Slc13a5 Foundation? Learn more here.

About this organization

Revenue

$286,889

Expenses

$172,923

Mission

Tess Research Foundation's goal is to find better treatment options for Slc13a5 deficiency, a severe form of epilepsy beginning in infancy. Slc13a5 deficiency is a newly discovered, rare disease. Tess Research Foundation funds medical research, connects doctors and patients to researchers, and raises awareness and provides support and education to affected families through a website, emails, and an online support group.

About

Funding scientific research Tess Research Foundation's goal is to find better treatment options for Slc13a5 deficiency, a severe form of epilepsy beginning in infancy. Slc13a5 deficiency is a newly discovered, rare disease. Tess Research Foundation funds medical research, connects doctors and patients to researchers, and raises awareness and provides support and education to affected families through a website, emails, and an online support group.

Interesting data from their 2020 990 filing

The non-profit's aim, as indicated in the filing, is “Tess research foundation's goal is to find better treatment options for slc13a5 deficiency, a severe form of epilepsy beginning in infancy. slc13a5 deficiency is a newly discovered, rare disease. tess research foundation funds medical research, connects doctors and patients to researchers, and raises awareness and provides support and education to affected families through a website, emails, and an online support group.”.

When referring to its functions, they were specified as: “Tess research foundation's goal is to find better treatment options for slc13a5 deficiency, a severe form of epilepsy beginning in infancy. slc13a5 deficiency is a newly discovered, rare disease. tess research foundation funds medical research, connects doctors and patients to researchers, and raises awareness and provides support and education to affected families through a website, emails, and an online support group.”.

  • The non-profit has reported their operating state as CA, as required by law.
  • As stated in the filing, the non-profit's address in 2020 was 655 OAK GROVE AVENUE NO 53, MENLO PARK, CA, 94026.
  • The non-profit's form reports a total of 0 employees as of 2020.
  • Is not a private foundation.
  • Expenses are between $100,000 and $250,000.
  • Revenue is between $250,000 and $500,000.
  • Revenue less expenses is $113,966.
  • The organization has 10 independent voting members.
  • The organization was formed in 2015.
  • The organization pays $0 in salary, compensation, and benefits to its employees.
  • The organization pays $259 in fundraising expenses.

By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.